Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35


Prevalence of double-stranded RNA virus in Trichomonas vaginalis isolated in Italy and association with the symbiont Mycoplasma hominis.

Margarita V, Marongiu A, Diaz N, Dessì D, Fiori PL, Rappelli P.

Parasitol Res. 2019 Dec;118(12):3565-3570. doi: 10.1007/s00436-019-06469-6. Epub 2019 Nov 7.


MHO_0730 as a Surface-Exposed Calcium-Dependent Nuclease of Mycoplasma hominis Promoting Neutrophil Extracellular Trap Formation and Escape.

Cacciotto C, Dessì D, Cubeddu T, Cocco AR, Pisano A, Tore G, Fiori PL, Rappelli P, Pittau M, Alberti A.

J Infect Dis. 2019 Nov 6;220(12):1999-2008. doi: 10.1093/infdis/jiz406.


Trichomonas vaginalis and Mycoplasma hominis: new tales of two old friends.

Dessì D, Margarita V, Cocco AR, Marongiu A, Fiori PL, Rappelli P.

Parasitology. 2019 Aug;146(9):1150-1155. doi: 10.1017/S0031182018002135. Epub 2019 Jan 8.


SuperNoder: a tool to discover over-represented modular structures in networks.

Dessì D, Cirrone J, Recupero DR, Shasha D.

BMC Bioinformatics. 2018 Sep 10;19(1):318. doi: 10.1186/s12859-018-2350-8.


Trichomonas vaginalis Transports Virulent Mycoplasma hominis and Transmits the Infection to Human Cells after Metronidazole Treatment: A Potential Role in Bacterial Invasion of Fetal Membranes and Amniotic Fluid.

Thi Trung Thu T, Margarita V, Cocco AR, Marongiu A, Dessì D, Rappelli P, Fiori PL.

J Pregnancy. 2018 Aug 2;2018:5037181. doi: 10.1155/2018/5037181. eCollection 2018.


Functional models and extending strategies for ecological networks.

Fenu G, Pau PL, Dessì D.

Appl Netw Sci. 2017;2(1):10. doi: 10.1007/s41109-017-0032-5. Epub 2017 May 25.


Symbiotic Association with Mycoplasma hominis Can Influence Growth Rate, ATP Production, Cytolysis and Inflammatory Response of Trichomonas vaginalis.

Margarita V, Rappelli P, Dessì D, Pintus G, Hirt RP, Fiori PL.

Front Microbiol. 2016 Jun 20;7:953. doi: 10.3389/fmicb.2016.00953. eCollection 2016.


Prevalence of Trichomonas vaginalis infection in symptomatic and asymptomatic women in Central Vietnam.

Ton Nu PA, Nguyen VQ, Cao NT, Dessì D, Rappelli P, Fiori PL.

J Infect Dev Ctries. 2015 Jul 4;9(6):655-60. doi: 10.3855/jidc.7190.


Ultrastructural and biochemical characterization of mechanically adaptable collagenous structures in the edible sea urchin Paracentrotus lividus.

Barbaglio A, Tricarico S, Ribeiro AR, Di Benedetto C, Barbato M, Dessì D, Fugnanesi V, Magni S, Mosca F, Sugni M, Bonasoro F, Barbosa MA, Wilkie IC, Candia Carnevali MD.

Zoology (Jena). 2015 Jun;118(3):147-60. doi: 10.1016/j.zool.2014.10.003. Epub 2015 Mar 18.


Kinetics of circulating antibody response to Trichomonas vaginalis: clinical and diagnostic implications.

Ton Nu PA, Rappelli P, Dessì D, Nguyen VQ, Fiori PL.

Sex Transm Infect. 2015 Dec;91(8):561-3. doi: 10.1136/sextrans-2014-051839. Epub 2015 Apr 17.


Molecular epizootiology and diagnosis of porcine babesiosis in Sardinia, Italy.

Zobba R, Nuvoli AM, Sotgiu F, Lecis R, Spezzigu A, Dore GM, Masia MA, Cacciotto C, Parpaglia ML, Dessì D, Pittau M, Alberti A.

Vector Borne Zoonotic Dis. 2014 Oct;14(10):716-23. doi: 10.1089/vbz.2014.1648.


Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responses.

Twu O, Dessí D, Vu A, Mercer F, Stevens GC, de Miguel N, Rappelli P, Cocco AR, Clubb RT, Fiori PL, Johnson PJ.

Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8179-84. doi: 10.1073/pnas.1321884111. Epub 2014 May 19.


Waiting time prioritisation for specialist services in Italy: the homogeneous waiting time groups approach.

Mariotti G, Siciliani L, Rebba V, Fellini R, Gentilini M, Benea G, Bertoli P, Bistolfi L, Brugaletta S, Camboa P, Casucci P, Dessi D, Faronato P, Galante M, Gioffredi A, Guarino TM, Pofi E, Liva C.

Health Policy. 2014 Jul;117(1):54-63. doi: 10.1016/j.healthpol.2014.01.018. Epub 2014 Feb 3.


Association of Trichomonas vaginalis with its symbiont Mycoplasma hominis synergistically upregulates the in vitro proinflammatory response of human monocytes.

Fiori PL, Diaz N, Cocco AR, Rappelli P, Dessì D.

Sex Transm Infect. 2013 Sep;89(6):449-54. doi: 10.1136/sextrans-2012-051006. Epub 2013 Apr 30.


A simple, rapid and inexpensive technique to bind small peptides to polystyrene surfaces for immunoenzymatic assays.

Cuccuru MA, Dessì D, Rappelli P, Fiori PL.

J Immunol Methods. 2012 Aug 31;382(1-2):216-9. doi: 10.1016/j.jim.2012.05.023. Epub 2012 Jun 7.


Trichomonas vaginalis pathobiology new insights from the genome sequence.

Hirt RP, de Miguel N, Nakjang S, Dessi D, Liu YC, Diaz N, Rappelli P, Acosta-Serrano A, Fiori PL, Mottram JC.

Adv Parasitol. 2011;77:87-140. doi: 10.1016/B978-0-12-391429-3.00006-X. Review.


Hydrogenosome-localization of arginine deiminase in Trichomonas vaginalis.

Morada M, Smid O, Hampl V, Sutak R, Lam B, Rappelli P, Dessì D, Fiori PL, Tachezy J, Yarlett N.

Mol Biochem Parasitol. 2011 Mar;176(1):51-4. doi: 10.1016/j.molbiopara.2010.10.004. Epub 2010 Nov 11.


Arginine metabolism in Trichomonas vaginalis infected with Mycoplasma hominis.

Morada M, Manzur M, Lam B, Tan C, Tachezy J, Rappelli P, Dessì D, Fiori PL, Yarlett N.

Microbiology. 2010 Dec;156(Pt 12):3734-3743. doi: 10.1099/mic.0.042192-0. Epub 2010 Jul 23.


Rapid detection of coinfections by Trichomonas vaginalis, Mycoplasma hominis, and Ureaplasma urealyticum by a new multiplex polymerase chain reaction.

Diaz N, Dessì D, Dessole S, Fiori PL, Rappelli P.

Diagn Microbiol Infect Dis. 2010 May;67(1):30-6. doi: 10.1016/j.diagmicrobio.2009.12.022.


Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis.

Carlton JM, Hirt RP, Silva JC, Delcher AL, Schatz M, Zhao Q, Wortman JR, Bidwell SL, Alsmark UC, Besteiro S, Sicheritz-Ponten T, Noel CJ, Dacks JB, Foster PG, Simillion C, Van de Peer Y, Miranda-Saavedra D, Barton GJ, Westrop GD, Müller S, Dessi D, Fiori PL, Ren Q, Paulsen I, Zhang H, Bastida-Corcuera FD, Simoes-Barbosa A, Brown MT, Hayes RD, Mukherjee M, Okumura CY, Schneider R, Smith AJ, Vanacova S, Villalvazo M, Haas BJ, Pertea M, Feldblyum TV, Utterback TR, Shu CL, Osoegawa K, de Jong PJ, Hrdy I, Horvathova L, Zubacova Z, Dolezal P, Malik SB, Logsdon JM Jr, Henze K, Gupta A, Wang CC, Dunne RL, Upcroft JA, Upcroft P, White O, Salzberg SL, Tang P, Chiu CH, Lee YS, Embley TM, Coombs GH, Mottram JC, Tachezy J, Fraser-Liggett CM, Johnson PJ.

Science. 2007 Jan 12;315(5809):207-12.


Mycoplasma hominis and Trichomonas vaginalis: a unique case of symbiotic relationship between two obligate human parasites.

Dessì D, Rappelli P, Diaz N, Cappuccinelli P, Fiori PL.

Front Biosci. 2006 Sep 1;11:2028-34. Review.


In vitro acanthamoebicidal activity of a killer monoclonal antibody and a synthetic peptide.

Fiori PL, Mattana A, Dessì D, Conti S, Magliani W, Polonelli L.

J Antimicrob Chemother. 2006 May;57(5):891-8. Epub 2006 Feb 28.


Qualitatively distinct patterns of cytokines are released by human dendritic cells in response to different pathogens.

Scott K, Manunta M, Germain C, Smith P, Jones M, Mitchell P, Dessi D, Branigan Bamford K, Lechler RI, Fiori PL, Foster GR, Lombardi G.

Immunology. 2005 Oct;116(2):245-54.


Mycoplasma hominis and Trichomonas vaginalis symbiosis: multiplicity of infection and transmissibility of M. hominis to human cells.

Rappelli P, Carta F, Delogu G, Addis MF, Dessì D, Cappuccinelli P, Fiori PL.

Arch Microbiol. 2001 Jan;175(1):70-4.


Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2.

Mantovani G, Gebbia V, Airoldi M, Bumma C, Contu P, Bianchi A, Ghiani M, Dessì D, Massa E, Curreli L, Lampis B, Lai P, Mulas C, Testa A, Proto E, Cadeddu G, Tore G.

Cancer Immunol Immunother. 1998 Nov;47(3):149-56.


Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.

Mantovani G, Ghiani M, Lai P, Maccio A, Dessi D, Succu G, Massa D, Curreli L, Mulas C, Esu S, Proto E, Cadeddu G, Tore G.

Oncol Rep. 1998 Nov-Dec;5(6):1499-505.


Medroxyprogesterone acetate and megestrol acetate reduce cisplatin-induced serotonin release from human peripheral blood mononuclear cells of cancer patients.

Mantovani G, Macciò A, Lai P, Esu S, Massa E, Santona MC, Massa D, Dessì D, Ghiani M.

Oncol Rep. 1998 Jan-Feb;5(1):121-4.


Tumor-associated lympho-monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines.

Mantovani G, Macciò A, Pisano M, Versace R, Lai P, Esu S, Massa E, Ghiani M, Dessì D, Melis GB, Del Giacco GS.

Int J Cancer. 1997 May 29;71(5):724-31.


Medroxyprogesterone acetate reduces the production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients.

Mantovani G, Macciò A, Esu S, Lai P, Santona MC, Massa E, Dessì D, Melis G, Del Giacco S.

Biochem Soc Trans. 1997 May;25(2):296S. No abstract available.


Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients.

Mantovani G, Macciò A, Esu S, Lai P, Santona MC, Massa E, Dessì D, Melis GB, Del Giacco GS.

Eur J Cancer. 1997 Apr;33(4):602-7.


Clinical and immunological evaluation of schizophyllan (SPG) in combination with standard chemotherapy in patients with head and neck squamous cell carcinoma.

Mantovani G, Bianchi A, Curreli L, Ghiani M, Astara G, Lampis B, Santona M, Dessi D, Esu S, Lai P, Massa E, Maccio A, Proto E.

Int J Oncol. 1997 Jan;10(1):213-21.


Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinoma.

Mantovani G, Gebbia V, Proto E, Cossu F, Bianchi A, Curreli L, Ghiani M, Massa E, Astara G, Lampis B, Dessi D, Santona M.

Int J Oncol. 1996 Nov;9(5):1035-43.


Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer.

Mantovani G, Gebbia V, Proto E, Cossu F, Bianchi A, Curreli L, Ghiani M, Astara G, Lampis B, Dessi D, Santona M, Massa E.

Int J Oncol. 1996 Sep;9(3):571-8.


Supplemental Content

Support Center